Table of contents

ORIGINAL ARTICLES

• Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population (1 August, 2004)

  H. E. Lambert, W. M. Gregory, A. E. Nelstrop, G. J. S. Rustin
• Number of residual nodules, better than size, defines optimal surgery in advanced epithelial ovarian cancer (1 August, 2004)

  E. Stoeckle, P. Paravis, A. Floquet, L. Thomas, C. Tunon De Lara, E. Bussières, G. Macgrogan, V. Picot, A. Avril
• Prognostic importance of the time interval from surgery to chemotherapy in treatment of ovarian carcinoma (1 August, 2004)

  B. Sorbe
• Whole-abdomen, single-dose consolidation radiotherapy in patients with pathologically confirmed complete remission of advanced ovarian epithelial carcinoma: a long-term survival analysis (1 August, 2004)

  A. Debby, T. Levy, H. Hayat, Y. Brenner, M. Glezerman, J. Menczer
• Second-line therapy of advanced ovarian cancer with GnRH analogs (1 August, 2004)

  G. Balbi, L. D. Piano, A. Cardone, G. Cirelli
• Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients (1 August, 2004)

  S. Tangjitgamol, H. T. See, S. Manusirivithaya, C. F. Levenback, D. M. Gershenson, J. J. Kavanagh
• Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma (1 August, 2004)

  M. R. Raspollini, G. Amunni, A. Villanucci, G. Baroni, V. Boddi, G. L. Taddei
• Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts (1 August, 2004)

  E. S. Van Laar, E. Izbicka, S. Weitman, L. Medina-Gundrum, J. R. Macdonald, S. J. Waters
• Do the pelvic lymph nodes predict the parametrial status in cervical cancer stages IB–IIA? (1 August, 2004)

  R. Puente, S. Guzman, E. Israel, M. T. Poblete
• The surgery of ‘inguino-femoral’ lymph nodes: is it adequate or excessive? (1 August, 2004)

  C. N. Hudson, H. Shulver, D. C. Lowe
• Surgical resection of locally recurrent cervical cancer: a single institutional 70 patient series (1 August, 2004)

  V. Moutardier, G. Houvenaeghel, M. Martino, B. Lelong, V. J. Bardou, M. Resbeut, J. R. Delpero
• Minilaparotomy for type II and III radical hysterectomy: technique, feasibility, and complications (1 August, 2004)

  A. Fagotti, F. Fanfani, A. Ercoli, L. Patrizi, S. Mancuso, G. Scambia
• Prospective phase I/II study of irradiation and concurrent chemotherapy for recurrent cervical cancer after radical hysterectomy (1 August, 2004)

  P. W. Grigsby
• Conventional 4-field box radiotherapy technique for cancer cervix: potential for geographic miss without CECT scan-based planning (1 August, 2004)

  Y. S. Nagar, S. Singh, S. Kumar, P. Lal
• Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study (1 August, 2004)

  L. R. Bigler, J. Tate Thigpen, J. A. Blessing, J. Fiorica, B. J. Monk
• Vulvar cancer patients' quality of life: a qualitative assessment (1 August, 2004)

  M. Janda, A. Obermair, D. Cella, A. J. Crandon, M. Trimmel
• Effect of daidzein on cell growth, cell cycle, and telomerase activity of human cervical cancer in vitro

  (1 August, 2004)

  J. M. Guo, G. Z. Kang, B. X. Xiao, D. H. Liu, S. Zhang
• Relation between deranged antioxidant system and cervical neoplasia (1 August, 2004)

  Y. T. Kim, J. W. Kim, J. S. Choi, S. H. Kim, E. K. Choi, N. H. Cho
• HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas (1 August, 2004)

  M. Graflund, B. Sorbe, S. Sigurdardóttir, M. Karlsson
• Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer (1 August, 2004)

  H. J. Yang, V. W. S. Liu, P. C. K. Tsang, A. M. W. Yip, K. F. Tam, L. C. Wong, T. Y. Ng, H. Y. S. Ngan
• Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III (1 August, 2004)

  J. A. Fonseca-Moutinho, E. Cruz, L. Carvalho, H. J. M. Prazeres, M. M. P. De Lacerda, D. P. Da Silva, F. Mota, C. F. De Oliveira
• Prospective self-controlled study on prevention of hysteroscopic dissemination in endometrial carcinoma (1 August, 2004)

  K. W. K. Lo, T. H. Cheung, S. F. Yim, M. Y. Yu, L. Y. S. Chan, T. K. H. Chung
• High-risk endometrial cancer in young indigent women (1 August, 2004)

  A. Ben-Arie, S. Perlman, Y. Hazan, L. A. Solomon, C. Edwards, A. L. Kaplan
• The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients (1 August, 2004)

  W. A. A. Tjalma, P. A. Van Dam, A. P. Makar, D. J. Cruickshank
• The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma (1 August, 2004)

  N. Macwhinnie, H. Monaghan
• APC, β-catenin, and E-cadherin and the development of recurrent endometrial carcinoma (1 August, 2004)

  J. M. A. Pijnenborg, N. Kisters, M. Van Engeland, G. A. J. Dunselman, J. De Haan, A. F. P. M. De Goeij, P. G. Groothuis
• Molecular differences between RER⁺ and RER^– sporadic endometrial carcinomas in a large population-based series

  (1 August, 2004)

  N. D. Macdonald, H. B. Salvesen, A. Ryan, S. Malatos, I. Stefansson, O. E. Iversen, L. A. Akslen, S. Das, I. J. Jacobs
• Evaluation and management of brain metastatic patients with high-risk gestational trophoblastic tumors (1 August, 2004)

  F. Ghaemmaghami, N. Behtash, N. Memarpour, K. Soleimani, P. Hanjani, F. A. Hashemi
• Doppler study of myometrium in invasive gestational trophoblastic disease (1 August, 2004)

  S. Oguz, A. Sargin, H. Aytan, S. Kelekci, H. Dumanli
• Is normal β-hCG regression curve helpful in the diagnosis of persistent trophoblastic disease? (1 August, 2004)

  N. Behtash, F. Ghaemmaghami, H. Honar, K. Riazi, A. Nori, M. Modares, A. Mousavi
• The changes of gene expression profiles in hydatidiform mole and choriocarcinoma with hyperplasia of trophoblasts (1 August, 2004)

  J. Q. Cui, Y. F. Shi, H. J. Zhou, J. Q. Li